Stock screener

BBIO

Conviction 53HealthcareScan · Tue, Sep 8, 2026
BBIO$74.76-0.11%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
3
4
3
2
Vol MA14 1.68M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
BridgeBio Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.bridgebio.com ↗
Price74.76
Change-0.11%
Gap-1.98%
Rel volume0.73×
Avg volume1.97M
Avg $ vol157.63M
SMA 2079.53
SMA 5080.69
SMA 20073.89
Price vs 50-7.35%
Price vs 200+1.18%
MA stackmixed
50/200 cross—
Supertrenddown · 81.39
RSI (14)32
MACD hist-0.74
MACD cross—
Stoch %K / %D11 / 7
ADX (14)18
+DI / −DI22 / 27
RSI divergence—
MACD divergenceBullish
ATR %+3.23%
ADR %3.05%
52w high90.17
52w low49.00
From 52w high-17.09%
Above 52w low+52.57%
New 52w highNo
SqueezeOff
Bollinger width15.37%
%B0.11
Donchian pos8.71%
Donchian high89.49
Donchian low73.36
AVWAP (52w high)83.38
vs AVWAP high-10.34%
AVWAP (52w low)71.88
vs AVWAP low+4.01%
OBV trendDown
Chaikin MF (20)-0.26
Today vs 20d0.73×
Avg vol (14d)1.68M
Avg vol (20d)1.97M
Avg $ vol (20d)157.63M
Market cap14.61B
RS 3m (vs SPY)+6.27%
RS 6m (vs SPY)-0.04%
RS line new highNo
Trend template5/8
Technical rank30.8
1 week-2.39%
1 month-11.51%
3 months+10.97%
6 months+13.89%
1 year+40.05%
YTD-4.44%
P/E—
P/B-5.81
P/S29.11
P/FCF-32.69
EPS-3.78
Div yield0.01%
ROE—
ROA—
Debt/Eq-0.00
Current1.23
EV/EBITDA-26.91
Gross margin—
Net margin—
Rev growth126.26%
EPS growth—
Price target109.44
Target upside46.39%
Analyst ratingBuy
Institutional115.37%
Ent. value13.94B
Revenue243.68M
Net income-69K
Gross profit—
Free cash flow-447.01M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out195.86M
Employees839
ListedThu, Jun 27, 2019
Free float149.14M
Float %76.2%
Short interest23.32M
Days to cover10.8d
Short volume21.5%
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.78 vs −$0.64
Last surprise-21.9% miss
Setup gradeC
Conviction53 / 100
Pattern quality—
Tech rank30.8 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance87.91
Support76.57
Days since event—
Candle confirm—
News sentiment—

Financials as of Sun, Jun 30, 2019 · quarterly.

Congress activity

Disclosed STOCK Act trades in BBIO · 4 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-11
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-19
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-22
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in BBIO · 10 sells

InsiderSideShares
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-19
Sell100
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-19
Sell1.8K
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-19
Sell8.1K
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-18
Sell1.2K
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-18
Sell14.6K
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-18
Sell17.28K
Kumar Neil
Chief Executive Officer · Common Stock · 2026-08-18
Sell1.9K
Kumar Neil
Chief Executive Officer · Restricted Stock Units · 2026-08-16
Exercise11.55K
Kumar Neil
Chief Executive Officer · Restricted Stock Units · 2026-08-16
Exercise6.52K
Trimarchi Thomas
President and CFO · Common Stock · 2026-08-16
Tax22.78K

SEC filings

EDGAR filings in BBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.